STAT+: South Africa and J&J reach a deal to widen access to a key tuberculosis treatment
South African antitrust authorities ended an investigation into Johnson & Johnson and its Janssen subsidiary…
Category: Johnson & Johnson
STAT+: Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines
The owners of a drug wholesaler have been indicted for their alleged role in a…
STAT+: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers
When it comes to bringing an experimental drug to market and selling it, Novo Nordisk,…
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs…
STAT+: In first big randomized trial, Abiomed’s heart pump reduced deaths in heart attack patients
A controversial heart pump from Abiomed reduced the number of deaths in severe heart attack…
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people…
STAT+: J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer
Johnson & Johnson has accused a long-standing employee of taking thousands of confidential files about…
In a showy hearing, Bernie Sanders gets few answers about lower drug prices
WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater. The hearing, featuring Merck…
STAT+: A sweeping new lawsuit asks: Are employers liable if they overpay for drugs?
Johnson & Johnson faces a consequential new class action lawsuit — not in its role…
STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena
WASHINGTON — Merck CEO Robert Davis and Johnson and Johnson CEO Joaquin Duato have agreed…
STAT+: Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the…
STAT+: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug
SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now…
STAT+: J&J to emphasize cancer drugs and stop much of its vaccine research
Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis…
STAT+: In lung cancer, J&J data amount to latest salvo against AstraZeneca
MADRID — A competition has been brewing between two pharma titans — Johnson & Johnson…
STAT+: FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools
The Food and Drug Administration is following through on its promise to regulate more health…